Bone regeneration from mesenchymal stem cells (MSCs) and compact bone-derived MSCs as an animal model

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) have emerged as a promising alternative to traditional surgical techniques. The purpose of this review is to document the current state of research and identify future research directions. At present, no specific markers have been shown to specifically identify MSCs. The most commonly reported positive markers are CD105, CD90, CD44, CD73, CD29, CD13, CD34, CD146, CD106, CD54 and CD166. The most frequently reported negative markers are CD34, CD14, CD45, CD11b, CD49d, CD106, CD10 and CD31. Regarding the source of MSCs, bone marrow-derived MSCs are the most frequently studied MSCs in bone regeneration; however, no reports have demonstrated advantages of bone marrow-derived MSCs over other types of MSCs in bone regeneration. For the purpose of clinical use, serum-free media is recommended to avoid risks connected with the use of animal products. Attempts have been made to develop defined serum-free media for animal and human MSC growth; however, most products have demonstrated only limited performance. Tumorigenesis is the other major problem in MSC regeneration. It is strongly recommended to prepare MSCs for tissue regeneration at early passages to avoid potential chromosomal abnormalities.

Original languageEnglish
Pages (from-to)35-44
Number of pages10
JournalJapanese Dental Science Review
Volume49
Issue number1
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Bone Regeneration
Mesenchymal Stromal Cells
Animal Models
Serum-Free Culture Media
Regeneration
Bone Marrow
Cortical Bone
Chromosome Aberrations
Carcinogenesis

Keywords

  • Bone regeneration
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

@article{ce96d324dee84444bc81f56dc86b8ef1,
title = "Bone regeneration from mesenchymal stem cells (MSCs) and compact bone-derived MSCs as an animal model",
abstract = "Mesenchymal stem cells (MSCs) have emerged as a promising alternative to traditional surgical techniques. The purpose of this review is to document the current state of research and identify future research directions. At present, no specific markers have been shown to specifically identify MSCs. The most commonly reported positive markers are CD105, CD90, CD44, CD73, CD29, CD13, CD34, CD146, CD106, CD54 and CD166. The most frequently reported negative markers are CD34, CD14, CD45, CD11b, CD49d, CD106, CD10 and CD31. Regarding the source of MSCs, bone marrow-derived MSCs are the most frequently studied MSCs in bone regeneration; however, no reports have demonstrated advantages of bone marrow-derived MSCs over other types of MSCs in bone regeneration. For the purpose of clinical use, serum-free media is recommended to avoid risks connected with the use of animal products. Attempts have been made to develop defined serum-free media for animal and human MSC growth; however, most products have demonstrated only limited performance. Tumorigenesis is the other major problem in MSC regeneration. It is strongly recommended to prepare MSCs for tissue regeneration at early passages to avoid potential chromosomal abnormalities.",
keywords = "Bone regeneration, Mesenchymal stem cells",
author = "Eiki Yamachika and Seiji Iida",
year = "2013",
month = "2",
doi = "10.1016/j.jdsr.2012.11.003",
language = "English",
volume = "49",
pages = "35--44",
journal = "Japanese Dental Science Review",
issn = "1882-7616",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Bone regeneration from mesenchymal stem cells (MSCs) and compact bone-derived MSCs as an animal model

AU - Yamachika, Eiki

AU - Iida, Seiji

PY - 2013/2

Y1 - 2013/2

N2 - Mesenchymal stem cells (MSCs) have emerged as a promising alternative to traditional surgical techniques. The purpose of this review is to document the current state of research and identify future research directions. At present, no specific markers have been shown to specifically identify MSCs. The most commonly reported positive markers are CD105, CD90, CD44, CD73, CD29, CD13, CD34, CD146, CD106, CD54 and CD166. The most frequently reported negative markers are CD34, CD14, CD45, CD11b, CD49d, CD106, CD10 and CD31. Regarding the source of MSCs, bone marrow-derived MSCs are the most frequently studied MSCs in bone regeneration; however, no reports have demonstrated advantages of bone marrow-derived MSCs over other types of MSCs in bone regeneration. For the purpose of clinical use, serum-free media is recommended to avoid risks connected with the use of animal products. Attempts have been made to develop defined serum-free media for animal and human MSC growth; however, most products have demonstrated only limited performance. Tumorigenesis is the other major problem in MSC regeneration. It is strongly recommended to prepare MSCs for tissue regeneration at early passages to avoid potential chromosomal abnormalities.

AB - Mesenchymal stem cells (MSCs) have emerged as a promising alternative to traditional surgical techniques. The purpose of this review is to document the current state of research and identify future research directions. At present, no specific markers have been shown to specifically identify MSCs. The most commonly reported positive markers are CD105, CD90, CD44, CD73, CD29, CD13, CD34, CD146, CD106, CD54 and CD166. The most frequently reported negative markers are CD34, CD14, CD45, CD11b, CD49d, CD106, CD10 and CD31. Regarding the source of MSCs, bone marrow-derived MSCs are the most frequently studied MSCs in bone regeneration; however, no reports have demonstrated advantages of bone marrow-derived MSCs over other types of MSCs in bone regeneration. For the purpose of clinical use, serum-free media is recommended to avoid risks connected with the use of animal products. Attempts have been made to develop defined serum-free media for animal and human MSC growth; however, most products have demonstrated only limited performance. Tumorigenesis is the other major problem in MSC regeneration. It is strongly recommended to prepare MSCs for tissue regeneration at early passages to avoid potential chromosomal abnormalities.

KW - Bone regeneration

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=84874260541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874260541&partnerID=8YFLogxK

U2 - 10.1016/j.jdsr.2012.11.003

DO - 10.1016/j.jdsr.2012.11.003

M3 - Article

AN - SCOPUS:84874260541

VL - 49

SP - 35

EP - 44

JO - Japanese Dental Science Review

JF - Japanese Dental Science Review

SN - 1882-7616

IS - 1

ER -